Gilmore Thomas D, Gerondakis Steve
Boston University, Biology Department, Boston, MA, USA.
Genes Cancer. 2011 Jul;2(7):695-711. doi: 10.1177/1947601911421925.
c-Rel is a member of the nuclear factor κB (NF-κB) transcription factor family. Unlike other NF-κB proteins that are expressed in a variety of cell types, high levels of c-Rel expression are found primarily in B and T cells, with many c-Rel target genes involved in lymphoid cell growth and survival. In addition to c-Rel playing a major role in mammalian B and T cell function, the human c-rel gene (REL) is a susceptibility locus for certain autoimmune diseases such as arthritis, psoriasis, and celiac disease. The REL locus is also frequently altered (amplified, mutated, rearranged), and expression of REL is increased in a variety of B and T cell malignancies and, to a lesser extent, in other cancer types. Thus, agents that modulate REL activity may have therapeutic benefits for certain human cancers and chronic inflammatory diseases.
c-Rel是核因子κB(NF-κB)转录因子家族的成员。与在多种细胞类型中表达的其他NF-κB蛋白不同,c-Rel的高表达主要见于B细胞和T细胞,许多c-Rel靶基因参与淋巴细胞的生长和存活。除了c-Rel在哺乳动物B细胞和T细胞功能中起主要作用外,人类c-rel基因(REL)是某些自身免疫性疾病(如关节炎、银屑病和乳糜泻)的易感基因座。REL基因座也经常发生改变(扩增、突变、重排),并且REL的表达在多种B细胞和T细胞恶性肿瘤中增加,在其他癌症类型中增加程度较小。因此,调节REL活性的药物可能对某些人类癌症和慢性炎症性疾病具有治疗益处。